Novartis spins off Alcon eye care unit as independent company in deal worth up to $5bn
- Consumables, Central Supplies
- Implantable Devices
- Surgical Equipment & Devices
- Full Acquisition
- Payment Includes Stock
- Includes Contract
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.